MCMedicalCodingSoftware
J9040

J9040: Injection, bleomycin sulfate, 15 units

HCPCSActiveBETOS O1D

J9040 is a HCPCS Level II code for injection, bleomycin sulfate, 15 units. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits: units per day

The most units of J9040 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
4 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
outpatient
4 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
DME supplier
4 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for J9040

Long descriptor
Injection, bleomycin sulfate, 15 units

The official wording. This is what the code means.

Short descriptor
Bleomycin sulfate injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1984

When CMS introduced the code.

BETOS
O1D

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J9040

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J9040 is not quite right, the correct code is very often within a few positions of it.

  • J9032Injection, belinostat, 10 mg
  • J9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
  • J9034Injection, bendamustine hcl (bendeka), 1 mg
  • J9035Injection, bevacizumab, 10 mg
  • J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
  • J9037Injection, belantamab mafodotin-blmf, 0.5 mgterminated
  • J9038Injection, axatilimab-csfr, 0.1 mg
  • J9039Injection, blinatumomab, 1 microgram
  • J9041Injection, bortezomib, 0.1 mg
  • J9042Injection, brentuximab vedotin, 1 mg
  • J9043Injection, cabazitaxel, 1 mg
  • J9044Injection, bortezomib, not otherwise specified, 0.1 mgterminated
  • J9045Injection, carboplatin, 50 mg
  • J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
  • J9047Injection, carfilzomib, 1 mg
  • J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026